Statins and cerebral vasomotor reactivity: implications for a new therapy?

Stroke. 2006 Oct;37(10):2446-8. doi: 10.1161/01.STR.0000239656.59618.d4. Epub 2006 Aug 24.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adult
  • Animals
  • Arginine / pharmacology
  • Atorvastatin
  • Brain Ischemia / etiology
  • Brain Ischemia / prevention & control
  • Cerebrovascular Circulation / drug effects*
  • Clinical Trials, Phase II as Topic
  • Endothelium, Vascular / drug effects
  • Heptanoic Acids / pharmacology
  • Heptanoic Acids / therapeutic use
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypercholesterolemia / complications
  • Hypertension / complications
  • Intracranial Aneurysm / complications
  • Mice
  • Middle Cerebral Artery / diagnostic imaging
  • Nitric Oxide / physiology
  • Pravastatin / pharmacology
  • Pravastatin / therapeutic use
  • Pyrroles / pharmacology
  • Pyrroles / therapeutic use
  • Randomized Controlled Trials as Topic
  • Research Design
  • Risk Factors
  • Simvastatin / pharmacology
  • Simvastatin / therapeutic use
  • Stroke / prevention & control
  • Subarachnoid Hemorrhage / drug therapy
  • Subarachnoid Hemorrhage / etiology
  • Ultrasonography, Doppler, Transcranial
  • Vasodilation / drug effects
  • Vasomotor System / drug effects*
  • Vasospasm, Intracranial / drug therapy
  • Vasospasm, Intracranial / etiology

Substances

  • Heptanoic Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrroles
  • Nitric Oxide
  • Arginine
  • Atorvastatin
  • Simvastatin
  • Pravastatin